Intra Cellular Therapies | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
ALKERMES USD 1.48B 63.7M 2025-03
Biogen USD 7.63B 169.2M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Cytokinetics USD 956.05M 151.89M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
J&J USD 71.55B 15.66B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Prothena USD 485.41M 49.57M 2024-12
RedHill Biopharma USD 15.7M 3K 2024-06
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03



Intra Cellular Therapies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.